| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/21/2004 | CN1490332A Recombinant human IA-2 antigen preparing method |
| 04/21/2004 | CN1490331A Sodium/hydrion inverse runner coding gene and application thereof |
| 04/21/2004 | CN1490325A Human gene RHBDL2 related to nervous system development |
| 04/21/2004 | CN1490324A Human gene NETRIN-G2 related to nervous system development |
| 04/21/2004 | CN1490323A Genome sequence of O-foot and mouth disease virus NYOO lines |
| 04/21/2004 | CN1490056A Immune method and composition for HIV-1 |
| 04/21/2004 | CN1490051A Recombined fowl pox living carrier vaccine for expression of FMDV protein |
| 04/21/2004 | CN1490049A CD26/DPP IV application for medicine in preparing treatment and/or diagnostic disease |
| 04/21/2004 | CN1146668C Oligonucleotide tags for sorting and identification |
| 04/21/2004 | CN1146666C Positive-negative selection for homologous recombination |
| 04/21/2004 | CN1146665C Method of modulating melanin synthesis |
| 04/21/2004 | CN1146664C Fusion polypeptides comprising and IgE-binding domain and HSA component, and their diagnostic and therapeutic uses |
| 04/21/2004 | CN1146663C Selection marker |
| 04/21/2004 | CN1146662C Movbillivirus L4 strain fusion protein gene |
| 04/21/2004 | CN1146661C Morbillivirus L4 strain hemagglutinin gene |
| 04/21/2004 | CN1146660C Intron carrying halamycin resistance gene and its application |
| 04/21/2004 | CN1146658C Modified phytase |
| 04/21/2004 | CN1146657C Construction and use of recombinant herpes simplex virus |
| 04/21/2004 | CN1146576C Proteins from mammaliam liver and their use in oncology |
| 04/21/2004 | CN1146441C Composition of containing lympha toxin beta receptor |
| 04/21/2004 | CN1146440C Vascular endothelial growth factor-B |
| 04/21/2004 | CN1146322C Pesticidal agent |
| 04/20/2004 | US6723898 Methods for the preparation of plants with changed sucrose concentration by transformation with a sucrose phosphate synthase nucleic acid |
| 04/20/2004 | US6723897 Methods for controlling gibberellin levels |
| 04/20/2004 | US6723896 Gene of interest, gene encoding a transcription factor, inducible gene encoding a recombinase under the control of a vertebrate hormone inducible promoter system, and a pair of recombination sites flanking a marker gene |
| 04/20/2004 | US6723895 Plants containing a cytosolic acetyl CoA-carboxylase nucleic acid |
| 04/20/2004 | US6723893 Mice having a mutant SOD-1-encoding transgene |
| 04/20/2004 | US6723841 Corticotropin-releasing factor2 receptors |
| 04/20/2004 | US6723839 Partial gene sequence from pelargonium to control ethylene levels in geraniums |
| 04/20/2004 | US6723837 Nucleic acid molecule and encoded protein associated with sterol synthesis and metabolism |
| 04/20/2004 | US6723832 Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof |
| 04/20/2004 | US6723708 Lithium chloride |
| 04/20/2004 | US6723707 Flanked by sv40 intron and polyadenylation signal sequences; genetic engineering |
| 04/20/2004 | US6723706 Modified antisense nucleotides complementary to a section of the human Ha-ras gene |
| 04/20/2004 | US6723705 Gene expression; activating t-cells ability to bind cd28 or ctla4 ligands; antimetastasis and anticarcinogenic agents |
| 04/20/2004 | US6723696 Drug screening for agents to treat hypercalcemia and osteoporosis |
| 04/20/2004 | US6723695 Cytotoxic epstein-barr virus (ebv) t-cell epitopes derived from ebv structural antigens; vaccines |
| 04/20/2004 | US6723567 Screening method for apoptosis and necrosis |
| 04/20/2004 | US6723562 DNA construct for transforming a yeast |
| 04/20/2004 | US6723561 Polypeptides |
| 04/20/2004 | US6723560 Using polyamide nucleic acid oligomers to engender a biological response |
| 04/20/2004 | US6723559 Nucleotide sequences coding polypeptide for use in the prevention of viral diseases |
| 04/20/2004 | US6723558 Comprise mixtures of 10,000 different recombinant viruses that each express a different hiv env variant containing both constant and variable regions; used as vaccines; envelop proteins (env) |
| 04/20/2004 | US6723556 Nucleic acid encoding a fragment of bovine luteinizing hormone/chorionic gonadotropin receptor |
| 04/20/2004 | US6723552 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 04/20/2004 | US6723551 Gene expression control; genetic engineering |
| 04/20/2004 | US6723550 Proteases from gram-positive organisms |
| 04/20/2004 | US6723549 Nucleotide sequences coding polypeptides for use in the treatment of textiles, laundering detergent and in pulp and papermaking |
| 04/20/2004 | US6723547 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
| 04/20/2004 | US6723546 Method for cloning and expression of BsaI restriction endonuclease and BsaI methylase in E. coli |
| 04/20/2004 | US6723545 Gene expression of polypeptide with 1,4-n-acetylglucosaminyl (galnac) transferase activity |
| 04/20/2004 | US6723544 Biotin biosynthetic genes |
| 04/20/2004 | US6723543 Mutant kanamycin nucleotidyltransferases from S. aureus |
| 04/20/2004 | US6723542 Peptide for use in human therapeutics and diagnostic compositions |
| 04/20/2004 | US6723539 It has high capacity for plasmid dna, and can be used in a packed bed with unfiltered feedstock and any type of chromatic technique |
| 04/20/2004 | US6723537 Microorganismal protein for use as diagnostic tool in genetic engineering |
| 04/20/2004 | US6723535 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment and prevention of cancer, skin, vascular, kidney and inflammatory disorders |
| 04/20/2004 | US6723534 Polypeptide for use in the treatment of fertility defects in humans |
| 04/20/2004 | US6723533 26934, a novel cytidine deaminase-like molecule and uses thereof |
| 04/20/2004 | US6723532 Plasmid for use in gene therapy |
| 04/20/2004 | US6723531 Method for modulating expression of exogenous genes in mammalian systems, and products related thereto |
| 04/20/2004 | US6723522 For use as an antibody, in expression systems, for measuring activity of the cotransporter, in drug screening and design, or as a reagent for making a probe or a pcr primer, making transgenic animal |
| 04/20/2004 | US6723521 Method for screening compounds which modulate glucose transporting activity |
| 04/20/2004 | US6723519 Compositions and method for determining the presence of rat PTTG peptide in a sample |
| 04/20/2004 | US6723518 Diagnosing mammary gland pathologies; obtain biopsies, screen for expression of chemokines, presence of chemokine indicates pathology |
| 04/20/2004 | US6723514 Compositions and methods for directly and rapidly analyzing the biochemical components of microorganisms |
| 04/20/2004 | US6723513 Sequencing method using magnifying tags |
| 04/20/2004 | US6723512 Methods using genetic package display for detecting and identifying protein-protein interactions that facilitate internalization and transgene expression and cells or tissues competent for the same and methods for evolving gene delivery vectors |
| 04/20/2004 | US6723511 Suppression of apoptosis in cell; obtain cells, incubate with blocking agent, monitor apoptosis in cells |
| 04/20/2004 | US6723504 Method for generating a gene library |
| 04/20/2004 | US6723323 Vibrio Cholerae vaccine candidates and method of their constructing |
| 04/20/2004 | US6723317 Binds to amino acid sequence 1,2 or 4; identification of human papillomavirus (hpv) 16 viral structures |
| 04/20/2004 | US6723315 Method for treating amyotrophic lateral sclerosis |
| 04/20/2004 | CA2223729C Universal primer sequence for multiplex dna amplification |
| 04/20/2004 | CA2044593C Method of in vivo delivery of functioning foreign genes |
| 04/20/2004 | CA1341454C Alpha-amidating enzyme compositions and processes for their production and use |
| 04/16/2004 | CA2408207A1 Peptides binding protein phosphatase 2a and polynucleotides coding them |
| 04/15/2004 | WO2004031769A1 Interaction detecting method and bioassay device, and bioassay-use substrate |
| 04/15/2004 | WO2004031767A2 Prevention of primary sjögren’s syndrome by ica69 deficiency |
| 04/15/2004 | WO2004031730A2 High sensitivity quantitation of peptides by mass spectrometry |
| 04/15/2004 | WO2004031416A1 Method and kit for quantitative and qualitative determination of human papillomavirus |
| 04/15/2004 | WO2004031415A2 Methods and compositions for rapid development of screening assays nuclear receptors |
| 04/15/2004 | WO2004031413A2 Method for diagnosing non-small cell lung cancers |
| 04/15/2004 | WO2004031409A2 Method for diagnosing chronic myeloid leukemia |
| 04/15/2004 | WO2004031404A1 Protein labelling with o6-alkylguanine-dna alkyltransferase |
| 04/15/2004 | WO2004031397A2 Detection of evolutionary bottlenecking by dna sequencing as a method to discover genes of value |
| 04/15/2004 | WO2004031393A1 A biosynthetic process of tdp-4-keto-6-deoxy-d-glucose as an intermediate of deoxy sugar |
| 04/15/2004 | WO2004031392A1 Mipp1 homologous nucleic acids and proteins involved in the regulation of energy homeostatis |
| 04/15/2004 | WO2004031391A1 Regulation of human pde1a |
| 04/15/2004 | WO2004031390A1 Vector system |
| 04/15/2004 | WO2004031389A1 Polynucleotides and polypeptides derived from lactobacillus rhamnosus hn001 |
| 04/15/2004 | WO2004031388A1 Factor participating in transcriptional regulation |
| 04/15/2004 | WO2004031387A1 Random drift mutagenesis |
| 04/15/2004 | WO2004031385A1 Human artificial chromosome (hac) vector |
| 04/15/2004 | WO2004031384A1 Mouse-origin proteins forming domain or use thereof |
| 04/15/2004 | WO2004031383A1 High yield heterologous expression cell lines for expression of gene products with human glycosylation pattern |
| 04/15/2004 | WO2004031381A1 Peptide capable of binding to nanographite structures |
| 04/15/2004 | WO2004031379A1 Proteins having polysaccharidase activity |
| 04/15/2004 | WO2004031376A2 Sesquiterpene synthases and methods of use |
| 04/15/2004 | WO2004031375A2 Regulation of human 3’, 5’ cyclic nucleotide phosphodiesterase pde1c |